Marty Bonick, president and CEO of Brentwood-based Ardent Health, saw his total compensation rise to more than $6.9 million in 2024, according to a proxy statement filed with the Securities and Exchange Commission.
Ardent went public in July. Here are the system’s five highest-earning executives in 2024:
1. Marty Bonick, president and CEO
- Salary: $1,060,485
- Stock awards: $4,520,272
- Non-equity incentive plan compensation: $1,345,300
- Other compensation: $13,200
- Total 2024 compensation: $6,939,257
- Total 2023 compensation: $2,209,277
2. Alfred Lumsdaine, CFO
- Salary: $622,632
- Stock awards: $2,220,890
- Non-equity incentive plan compensation: $571,192
- Other compensation: $13,200
- Total 2024 compensation: $3,427,914
- Total 2023 compensation: $1,317,434
3. David Schultz, president of hospital operations
- Salary: $652,116
- Stock awards: $1,347,291
- Non-equity incentive plan compensation: $554,894
- Other compensation: $461,557
- Total 2024 compensation: $3,015,858
- Total 2023 compensation: $725,607
4. Stephen Petrovich, executive vice president and general counsel
- Salary: $531,091
- Stock awards: $991,419
- Non-equity incentive plan compensation: $501,913
- Other compensation: $13,200
- Total 2024 compensation: $2,037,623
- Total 2023 compensation: $958,203
5. Ethan Chernin, president of health services
- Salary: $343,856
- Bonus: $50,000
- Stock awards: $750,016
- Non-equity incentive plan compensation: $268,037
- Other compensation: $80,610
- Total 2024 compensation: $1,492,519
- Total 2023 compensation: N/A (joined Ardent in May 2024)
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
